NCT06272851

Brief Summary

To compare the choroidal thickness in eyes of diabetic patients with eyes of age matched controls using optical coherence tomography.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
37mo left

Started Mar 2024

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Mar 2024May 2029

First Submitted

Initial submission to the registry

February 15, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 22, 2024

Completed
22 days until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2029

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2029

Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

5 years

First QC Date

February 15, 2024

Last Update Submit

February 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • comparison between choroidal thickness

    To compare choroidal thickness using optical coherence tomography between eyes of healthy individuals and diabetic patients without retinopathy

    2 years

Study Arms (2)

diabetics

Type 2 DM patients aged 30 to 80 years

Device: optical coherence tomography

non diabetics

non-diabetic healthy individuals

Device: optical coherence tomography

Interventions

measuring choroidal thickness using optical coherence tomography

diabeticsnon diabetics

Eligibility Criteria

Age30 Years - 95 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

known Type 2 DM patients aged 30 to 95 years either gender with no history of ocular treatment and non-diabetic healthy individuals who come to the hosoital

You may qualify if:

  • All known Type 2 DM patients aged 30 to 95 years either gender who presented to ophthalmology clinics in Assuit ophthalmology hospital with no history of ocular treatment (ocular treatment naïve) and visual acuity of 0.1 (6/60) or more that are able to complete an eye examination, and non-diabetic healthy individuals (HbA1c \<7) will be included in the study.

You may not qualify if:

  • Known diagnosis of any other retinal disease, glaucoma, neurodegenerative disease, and any significant media opacities that precluded fundus imaging and not giving consent will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng CY. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.

    PMID: 33940045BACKGROUND
  • Tan TE, Wong TY. Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne). 2023 Jan 9;13:1077669. doi: 10.3389/fendo.2022.1077669. eCollection 2022.

    PMID: 36699020BACKGROUND
  • Hassan H, Cheema A, Tahir MA, Nawaz HN. Comparison of choroidal thickness in eyes of diabetic patients with eyes of healthy individuals using optical coherence tomography in a tertiary care hospital. Pak J Med Sci. 2022 Jan-Feb;38(1):254-260. doi: 10.12669/pjms.38.1.4443.

    PMID: 35035435BACKGROUND
  • Endo H, Kase S, Saito M, Yokoi M, Takahashi M, Ishida S, Kase M. Choroidal Thickness in Diabetic Patients Without Diabetic Retinopathy: A Meta-analysis. Am J Ophthalmol. 2020 Oct;218:68-77. doi: 10.1016/j.ajo.2020.05.036. Epub 2020 Jun 20.

    PMID: 32574782BACKGROUND
  • Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina. 2012 Mar;32(3):563-8. doi: 10.1097/IAE.0b013e31822f5678.

    PMID: 22374157BACKGROUND
  • Tavares Ferreira J, Vicente A, Proenca R, Santos BO, Cunha JP, Alves M, Papoila AL, Abegao Pinto L. CHOROIDAL THICKNESS IN DIABETIC PATIENTS WITHOUT DIABETIC RETINOPATHY. Retina. 2018 Apr;38(4):795-804. doi: 10.1097/IAE.0000000000001582.

    PMID: 28267113BACKGROUND

MeSH Terms

Conditions

Choroid DiseasesDiabetes Mellitus

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Uveal DiseasesEye DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Mohammed Shehata Hussein

    Assiut University

    STUDY DIRECTOR
  • Dalia Mohamed El-Sebaity

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Islam Mohamed Gouda

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
NBMonier

Study Record Dates

First Submitted

February 15, 2024

First Posted

February 22, 2024

Study Start

March 15, 2024

Primary Completion (Estimated)

March 30, 2029

Study Completion (Estimated)

May 15, 2029

Last Updated

February 22, 2024

Record last verified: 2024-02